Press Releases - 2019-12-09

Date	Title	Company
09-Dec-2019	ADC Therapeutics Announces Oral Presentation of Interim Efficacy Data from Pivotal Phase 2 Clinical Trial of ADCT-402 (Loncastuximab Tesirine) in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma at 61st ASH Annual Meeting	ADC Therapeutics SA
09-Dec-2019	Stadius Biopharma to Present Data on Fully Human Antibodies for the Treatment of Candida Infections	Stadius Biopharma LLC
09-Dec-2019	Newron Pharmaceuticals to Request Type A FDA Meeting Prior to Unblinding of STARS Clinical Trial Data	Newron Pharmaceuticals S.p.A.
09-Dec-2019	Newron Pharmaceuticals to Request Type A FDA Meeting Prior to Unblinding of STARS Clinical Trial Data	Newron Pharmaceuticals S.p.A.
09-Dec-2019	MetP Pharma Receives US Patent for Drug Therapy of Demyelinating and Neuroinflammatory Diseases such as Multiple Sclerosis	B3C newswire
09-Dec-2019	MetP Pharma Receives US Patent for Drug Therapy of Demyelinating and Neuroinflammatory Diseases such as Multiple Sclerosis	B3C newswire
09-Dec-2019	The Alliance for Regenerative Medicine to host European ATMP Access Meeting in Brussels	The Alliance for Regenerative Medicine
09-Dec-2019	Bimekizumab Phase 3 Psoriasis Study Demonstrates Superiority Versus Humira®	UCB
09-Dec-2019	ReNeuron Group plc - Interim Results	ReNeuron Group plc
09-Dec-2019	Professor Amit Nathwani will present the Ham-Wasserman Lecture at the 61st ASH Annual Meeting	Freeline
09-Dec-2019	BC Platforms Partners with leading European Genomics Service Provider Life & Brain to Expand Genotyping Services Across Europe	BC Platforms
09-Dec-2019	UKCPA publish recommendations to avoid errors with Syntocinon® & Syntometrine®	UKCPA
09-Dec-2019	Bimekizumab Phase 3 Psoriasis Study Demonstrates Superiority Versus Humira®	UCB
09-Dec-2019	ViiV Healthcare submits New Drug Application to the FDA for fostemsavir, an investigational, first-in-class attachment inhibitor for the treatment of HIV in adults with few treatment options available	ViiV Healthcare
09-Dec-2019	Takeda and Enzyre to develop diagnostic device allowing hemophilia patients to determine their coagulation status at home	Takeda Pharmaceutical Company Limited
09-Dec-2019	PHARMASEAL Scoops its First Industry Award as Best Start-Up of the Year At Medilink East Midlands Business Awards 2019	PHARMASEAL
09-Dec-2019	PureTech Affiliate Vedanta Biosciences Awarded $5.8 Million CARB-X Grant to Accelerate Development of VE707 for Multi-Drug Resistant Infections	PureTech Health plc
09-Dec-2019	HUMMINGBIRD BIOSCIENCE RAISES US$19 MILLION IN SERIES B FINANCING	Hummingbird Bioscience
09-Dec-2019	PHASTAR Gains 2020 ‘Best Companies’ Accreditation for Employee Engagement	PHASTAR
09-Dec-2019	Orgenesis launches Point of Care cell and gene therapy centers within HYGEIA Group’s Greek hospital network	HYGEIA Group